書誌情報
P17-4. Pomalidomide + Bortezomib + Low-Dose Dexamethasone (PVd) in Relapsed / Refractory Multiple Myeloma : OPTIMISMM Japanese Subgroup Analysis
Kazutaka Sunami1, Kosei Matsue2, Kenshi Suzuki3, Naoki Takezako4, Atsushi Shinagawa5, Sanae Sakurai6, Hiromi Tamakoshi6, Tsvetan Biyukov7, Teresa Peluso7, Paul Richardson8
1National Hospital Organization Okayama Medical Center, 2Kameda Medical Center, 3Japanese Red Cross Medical Center, 4National Hospital Organization Disaster Medical Center, 5Hitachi General Hospital, 6Celgene K.K., 7Celgene International Sarl, 8Dana-Farber Cancer Institute
International Journal of Myeloma 9(1): 165-165, 2019.
個人会員・法人会員の方（IDが5または10で始まる方）
- 全文ダウンロード： 従量制、基本料金制の方共に121円(税込) です。
